跳至主要内容
临床试验/NCT02703948
NCT02703948已完成不适用

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Galderma R&D4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
60
试验地点
4
主要终点
Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

研究概览

简要总结

This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
  • Males or females, 22 years of age or older
  • Subjects seeking augmentation therapy for the lips.

排除标准

  • History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
  • Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.

结局指标

主要结局

Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Injection Technique Assessment of Restylane Silk... | 临床试验